Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rain Therapeutics Licenses MDM2 Inhibitor from Daiichi Sankyo

contractpharmaSeptember 03, 2020

Tag: Rain Therapeutics , Daiichi Sankyo , MDM2 inhibitor , RAIN-32 , cancer

PharmaSources Customer Service